AbbVie (NYSE: ABBV) today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Identification of each animal in a collective becomes possible even when individuals are never all visible simultaneously, enabling faster and more accurate analysis of collective behavior.
If you’re looking for a law school that will provide you with a well-rounded legal education, nationally recognized faculty, a breadth of course offerings, and countless practical opportunities, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results